These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The effect of temperature and hematocrit level of oxygenated cardioplegic solutions on myocardial preservation. Rousou JA; Engelman RM; Breyer RH; Otani H; Lemeshow S; Das DK J Thorac Cardiovasc Surg; 1988 Apr; 95(4):625-30. PubMed ID: 3352296 [TBL] [Abstract][Full Text] [Related]
11. The metabolic consequences of blood and crystalloid cardioplegia. Engelman RM; Rousou JH; Lemeshow S; Dobbs WA Circulation; 1981 Aug; 64(2 Pt 2):II67-74. PubMed ID: 6972829 [TBL] [Abstract][Full Text] [Related]
12. Studies of controlled reperfusion after ischemia. XIX. Reperfusate composition: benefits of blood cardioplegia over fluosol DA cardioplegia during regional reperfusion--importance of including blood components in the initial reperfusate. Acar C; Partington MT; Buckberg GD J Thorac Cardiovasc Surg; 1991 Feb; 101(2):284-93. PubMed ID: 1992239 [TBL] [Abstract][Full Text] [Related]
13. Effects of Hot shot on recovery after hypothermic ischemia in neonatal lamb heart. Nomura F; Forbess JM; Mayer EJ J Cardiovasc Surg (Torino); 2001 Feb; 42(1):1-7. PubMed ID: 11292898 [TBL] [Abstract][Full Text] [Related]
14. [Assessment of myocardial oxygen consumption during hypothermic perfusion on arrested heart with perfluorochemical and blood cardioplegia]. Tamura K Nihon Kyobu Geka Gakkai Zasshi; 1989 Apr; 37(4):612-21. PubMed ID: 2768936 [TBL] [Abstract][Full Text] [Related]
15. Ischemic myocardial protection. Comparison of nonoxygenated crystalloid, oxygenated crystalloid, and oxygenated fluorocarbon cardioplegic solutions. Tabayashi K; McKeown PP; Miyamoto M; Luedtke AE; Thomas R; Allen MD; Misbach GA; Ivey TD J Thorac Cardiovasc Surg; 1988 Feb; 95(2):239-46. PubMed ID: 3339891 [TBL] [Abstract][Full Text] [Related]